Original news and analysis on international IP policy
Whether laws enforcing transparency on costs would help curb extortionate drug prices in today’s world is hardly predictable now that pharma companies and their allies are lobbying governments to scupper any rules that would require them to disclose the real R&D costs and profits of their medicines and the rationale for charging what they do, writes Daniele Dionisio.
BRUSSELS -- Patents applications are on the rise in Europe the European Patent Office President Benoît Battistelli said today, with half of the applications coming from European inventors. The United States led followed by Germany, and Japan, and China showing a strong growth. The EPO president also announced the signature of an agreement with one trade union against a background of social unrest in the organisation.
Intense debate, reignited by a 2012 International Telecommunication Union roundtable on rampant patent litigation and the “innovation-stifling” use of intellectual property, together with the growing lack of standards bodies' patent policies, prompted the IEEE Standards Association (IEEE) last year to revisit parts of its patent policy that had been causing some concerns, Managing Director Konstantinos Karachalios said at a 17 February Oxfirst webinar.
The changes aim to clear up some ambiguities. Perhaps predictably, however, some pushback has arisen among industries affected by the change.
Passage of the Trans-Pacific Partnership agreement is the Obama administration's top trade priority this year, the Office of the United States Trade Representative said in its annual trade agenda released today. The agenda highlights intellectual property protection but also says all the right things on copyright limitations and exceptions, safe harbor for internet service providers, and the ability of countries to use flexibilities under international trade law.
KAMPALA, Uganda -- An Ebola vaccine trial is underway in Uganda, as the global search for an effective vaccine continues. The vaccine candidate was co-developed by the National Institute of Allergy and Infectious Diseases (NIAID), part of the United States National Institutes of Health (NIH), and GlaxoSmithKline (GSK), a United Kingdom-based pharmaceutical company.
The European Union and Canada have jointly announced the finalisation of the legal review for Canada-European Union Comprehensive Economic and Trade Agreement (CETA).
The saga of fights between the President of the European Patent Office, Benoît Battistelli, and the trade union SUEPO goes on with a recent decision to fire two and degrade one member of the trade union. Demonstrations at both the Netherlands and the Munich sites of the EPO continue, and further divisions between the president and the EPO Administrative Council are being reported. Battistelli spoke with Monika Ermert for Intellectual Property Watch in January about his view of the fight and about what else he has on his plate as he had decided to continue for one more term in office.
NAIROBI, Kenya -- As the budding East African pharmaceutical industry shows clear gains , experts at a pharmaceutical summit in Kenya underlined the sector as key to tackling challenges related to access to essential medicines in the region.
Delinkage of research and development costs from medicines prices could "vastly expand" access to medicines by drastically dropping costs of the knowledge component of health products, innovative medicines R&D facility UNITAID says in a new report.
By July trade negotiators from the United States and the European Union want to present a draft text that only has brackets for the “most sensitive issues” in the Transatlantic Trade and Investment Partnership (TTIP). This was announced by Ignacio Bercero, chief negotiator for the European Union, and his US counterpart Dan Mullaney during a press conference today after this week's 12th round of TTIP negotiations in Brussels.
The now-familiar item of intellectual property and innovation is on the agenda for next week’s regular meeting of the intellectual property committee of the World Trade Organization. This time under the item, a range of developed countries have proposed to discuss education and diffusion, and Switzerland has put forward a paper on nurturing a culture of innovation.
The United States has spent over a decade trying to rein in so-called “patent trolls.” Nevertheless, a recent study suggests that patent trolls are a bigger problem than ever.